Skip to main content

Tweets

Cochrane review of Stem cell transplantation in systemic sclerosis (3RCTs w/ 125 pts). Non‐myeloablative & myeloablative selective HSCT had moderate evidence for improved survival, skin thickness & function. But these had high Serious AE rates. https://t.co/VKciXY0klN https://t.co/LdMu3RrlZK

Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
Learn how to manage lupus: 'The Lupus Encyclopedia: A Comprehensive Guide for Patients and Families' - on #BookBuzz - https://t.co/hvnoFRiabA

Donald Thomas, MD @lupuscyclopedia ( View Tweet )

3 years 10 months ago
h/t @alhkim concluded. “Get Evusheld into your patients" - We add give aggressive out pt mgmnt for #Breakthrough @CCalabreseDO @philipcrobinson @drdavidliew B-cell depleting therapies ‘biggest threat’ for reduced SARS-CoV-2 mRNA vaccine response https://t.co/VZRwg0Q6cw

Leonard Calabrese @LCalabreseDO ( View Tweet )

3 years 10 months ago
Hyaluronic Acid Knee Injections Equivalent to Placebo In the United States, where over $300 million is spent annually on intraarticular hyaluronic acid injections, yet another study shows such therapy to be no better than placebo. https://t.co/NwJkyECfgM https://t.co/qGLQMWjQG4
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
Charcot (neuropathic) arthropathy of elbow due to Syringomyelia - review of 50 pts. Median age 45 yrs, 2/3 isolated elbow arthritis; other joints: shoulder > wrist > MCPs/IPs. 2/3 had Chiari malformations, sensory/motor deficits, or ulnar neuropathy https://t.co/2hEArpbL8p https://t.co/MK4VTzSSRB
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
Review of VTE risk with JAK inhibitors - Tofacitinib: 10mg or 5 mg bid - PE rates 0.5 & 0.3/100PY; higher w/ risk factors, VTE 0.35/100PY - Baricitinib: IR of DVT/PE was 0.5/100PY - Filgotinib: 200mg VTEs 0.2/100PY Most VTE occured in LT extension of RCT https://t.co/xvf0kQUMel https://t.co/Bj6fmkktP7
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
Dr. Jack Cush delivers this weeks rheumatology "weather report" with the best and least of news and journal articles from the past week on RheumNow. Are you a fan of our podcast? Please rate, like and review us wherever you get your podcast. https://t.co/uj6QF3EqlU https://t.co/lFpoRfkEqU
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
Melatonin Use Growing, Inappropriate & Potentially Unsafe With nearly 1/3 of adults, adolescents and children having sleep difficulties, many resort to using melatonin. But is it effective, safe and warranted? https://t.co/8TA76yAbwr https://t.co/ADYklo0yMz
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
Olokizumab, another IL-6 Inhibitor for RA This week's NEJM has published the efficacy results of a large phase 3 trial of olokizumab, a humanized monoclonal antibody that directly targets interleukin-6 (IL-6) in patients with rheumatoid arthritis (RA). https://t.co/VMz8xzffiZ https://t.co/eaA4CUWvrv
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
Hyaluronic Acid Knee Injections Equivalent to Placebo In the United States, where over $300 million is spent annually on intraarticular hyaluronic acid injections, yet another study shows such therapy to be no better than placebo. https://t.co/1pSVr3VI4t https://t.co/DvFN7WQdTp
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
Bullous Systemic Lupus Erythematosus (BSLE) BSLE is a rare blistering cutaneous manifestation of systemic lupus erythematosus (SLE). As goes SLE, bullous disease typically affects women, especially those of African descent. https://t.co/TBr7pGXjZ5 https://t.co/aq5dX3wQPX
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
Record Use of Marijuana and Hallucinogens in Young Adults The NY Times reports that a recent survey of drug use indicates that daily consumption of marijuana among young adults nearly doubled in the last decade. https://t.co/Dvj4nUNdtg https://t.co/BRkq8nb5sz
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
×